Loading...

Clinical use of amyloid-positron emission tomography neuroimaging: Practical and bioethical considerations

Until recently, estimation of β-amyloid plaque density as a key element for identifying Alzheimer's disease (AD) pathology as the cause of cognitive impairment was only possible at autopsy. Now with amyloid-positron emission tomography (amyloid-PET) neuroimaging, this AD hallmark can be detecte...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Alzheimers Dement (Amst)
Main Authors: Witte, Michael M., Foster, Norman L., Fleisher, Adam S., Williams, Monique M., Quaid, Kimberly, Wasserman, Michael, Hunt, Gail, Roberts, J. Scott, Rabinovici, Gil D., Levenson, James L., Hake, Ann Marie, Hunter, Craig A., Van Campen, Luann E., Pontecorvo, Michael J., Hochstetler, Helen M., Tabas, Linda B., Trzepacz, Paula T.
Format: Artigo
Sprog:Inglês
Udgivet: Elsevier 2015
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4878065/
https://ncbi.nlm.nih.gov/pubmed/27239516
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.dadm.2015.06.006
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!